Guide to Targeted Therapies: EGFR mutations in NSCLC
(Sprache: Englisch)
This concise, practical handbook discusses EGFR mutations in NSCLC, testing methods and technology, current and emerging therapies, and resources. It offers readers a fast synopsis of key studies and available treatment options.
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 53.50
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Guide to Targeted Therapies: EGFR mutations in NSCLC “
This concise, practical handbook discusses EGFR mutations in NSCLC, testing methods and technology, current and emerging therapies, and resources. It offers readers a fast synopsis of key studies and available treatment options.
Klappentext zu „Guide to Targeted Therapies: EGFR mutations in NSCLC “
Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
Inhaltsverzeichnis zu „Guide to Targeted Therapies: EGFR mutations in NSCLC “
Introduction.- The Human Epidermal growth factor Receptor (HER) family: structure and function.- Methods for EGFR mutation testing.- Predictive and prognostic implications of EGFR mutations.- EGFR-targeted therapies in non small cell lung cancer.- Conclusions.
Autoren-Porträt von Federico Cappuzzo
Federico Cappuzzo is the Director of the Medical Oncology Department (Ospedale Civile in Livorno, Italy), following posts as Assistant Professor (Ospedale Bellaria in Bologna, Italy, the Istituto Clinico Humanitas IRCCS in Milan, Italy, and University of Colorado in Denver, USA). Dr Cappuzzo is a member of the Italian Association in Medical Oncology (AIOM), European Society for Medical Oncology (ESMO), American Society Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer (IASCL). He also sits on the editorial board of Lung Cancer.
Bibliographische Angaben
- Autor: Federico Cappuzzo
- 2014, 2014, XI, 67 Seiten, 67 farbige Abbildungen, Masse: 12,7 x 20,1 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 3319030582
- ISBN-13: 9783319030586
- Erscheinungsdatum: 27.10.2014
Sprache:
Englisch
Kommentar zu "Guide to Targeted Therapies: EGFR mutations in NSCLC"
0 Gebrauchte Artikel zu „Guide to Targeted Therapies: EGFR mutations in NSCLC“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Guide to Targeted Therapies: EGFR mutations in NSCLC".
Kommentar verfassen